Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline H Chilton

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Infectious Disease Clinics of North America|January 14, 2015
Predictive values of models of Clostridium difficile infectionCaroline H Chilton, Jane Freeman
Current Opinion in Gastroenterology|November 9, 2023
Clostridioides difficile infections; new treatments and future perspectivesCharmaine Normington, Caroline H Chilton, Anthony M Buckley
Methods in Molecular Biology (Clifton, N.J.)|August 11, 2016
An In Vitro Model of the Human Colon: Studies of Intestinal Biofilms and Clostridium difficile InfectionGrace S Crowther, Mark H Wilcox, Caroline H Chilton
Plos One|August 25, 2016
Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin ProductionCaroline H Chilton, Grace S Crowther, Helen Ashwin, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 2015
Recurrence of dual-strain Clostridium difficile infection in an in vitro human gut modelGrace S Crowther, Caroline H Chilton, Sharie L Todhunter, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2012
Co-amoxiclav induces proliferation and cytotoxin production of Clostridium difficile ribotype 027 in a human gut modelCaroline H Chilton, Jane Freeman, Grace S Crowther, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2013
Evaluation of antimicrobial activity of ceftaroline against Clostridium difficile and propensity to induce C. difficile infection in an in vitro human gut modelSimon D Baines, Caroline H Chilton, Grace S Crowther, et al.
The Journal of Antimicrobial Chemotherapy|September 12, 2012
Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infectionGrace S Crowther, Simon D Baines, Sharie L Todhunter, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 5, 2026
Modulation of the gut microbiota as a novel strategy to prevent anastomotic leak after colorectal surgery: Systematic scoping reviewJack A Helliwell, Peter Sciberras, Alexios Dosis, et al.
Antimicrobial Agents and Chemotherapy|November 21, 2018
Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human ColonInes B Moura, Anthony M Buckley, Duncan Ewin, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Infectious Disease Clinics of North America|January 14, 2015
Predictive values of models of Clostridium difficile infectionCaroline H Chilton, Jane Freeman
Current Opinion in Gastroenterology|November 9, 2023
Clostridioides difficile infections; new treatments and future perspectivesCharmaine Normington, Caroline H Chilton, Anthony M Buckley
Methods in Molecular Biology (Clifton, N.J.)|August 11, 2016
An In Vitro Model of the Human Colon: Studies of Intestinal Biofilms and Clostridium difficile InfectionGrace S Crowther, Mark H Wilcox, Caroline H Chilton
Plos One|August 25, 2016
Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin ProductionCaroline H Chilton, Grace S Crowther, Helen Ashwin, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 2015
Recurrence of dual-strain Clostridium difficile infection in an in vitro human gut modelGrace S Crowther, Caroline H Chilton, Sharie L Todhunter, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2012
Co-amoxiclav induces proliferation and cytotoxin production of Clostridium difficile ribotype 027 in a human gut modelCaroline H Chilton, Jane Freeman, Grace S Crowther, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2013
Evaluation of antimicrobial activity of ceftaroline against Clostridium difficile and propensity to induce C. difficile infection in an in vitro human gut modelSimon D Baines, Caroline H Chilton, Grace S Crowther, et al.
The Journal of Antimicrobial Chemotherapy|September 12, 2012
Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infectionGrace S Crowther, Simon D Baines, Sharie L Todhunter, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 5, 2026
Modulation of the gut microbiota as a novel strategy to prevent anastomotic leak after colorectal surgery: Systematic scoping reviewJack A Helliwell, Peter Sciberras, Alexios Dosis, et al.
Antimicrobial Agents and Chemotherapy|November 21, 2018
Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human ColonInes B Moura, Anthony M Buckley, Duncan Ewin, et al.
Pageof 2